Effects of allopurinol on theophylline metabolism and clearance

Abstract
The effects of allopurinol on the plasma clearance and metabolism of theophylline in man were investigated under single-dose and multiple-dosing conditions. No change in theophylline clearance was found with the concomitant use of allopurinol but 1-methylxanthine (1MX), a theophylline metabolite not previously described in man, was detected in urine during control and allopurinol treatment phases under both single- and multiple-dosing conditions. 1MX excretion increased at the expense of 1-methyluric acid (IMU) during the allopurinol treatment phase. It is proposed that the secondary biotransformation of 1MX to IMU is mediated by xanthine oxidase.